Lv1
10 积分 2026-08-02 加入
Long-term Cardiovascular, Renal, and Safety Outcomes of Teprotumumab versus Systemic Glucocorticoids in Thyroid Eye Disease: A Target Trial Emulation
1天前
待确认
Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort Study
2天前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial
2天前
已完结
以改善眼部结局为导向的甲状腺眼病治疗理念的更新
6天前
已完结
皖公网安备34019202002308
